Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Alexion To Join With AZ Ahead Of US Soliris Biosimilars In 2025
Originator Shifting Patients To Next-Gen Ultomiris
Dec 14 2020
•
By
Dean Rudge
Amgen is aiming to get a slice of the US eculizumab market in 2025 with a biosimilar launch. • Source: Shutterstock
More from Biosimilars
More from Products
